Center for Substance Abuse Prevention; Notice of Meeting, 1650 [2015-00310]

Download as PDF 1650 Federal Register / Vol. 80, No. 8 / Tuesday, January 13, 2015 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse Notice of Closed Meetings asabaliauskas on DSK5VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Identification of Gene Variants for Addiction Related Traits by Next-Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3). Date: January 22, 2015. Time: 12:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 4234, MSC 9550, Bethesda, MD 02892, 301– 443–9511, jrao@nida.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA I/ START Small Grant Review (R03). Date: February 19, 2015. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Virtual Meeting). Contact Person: Minna Liang, Ph.D., Scientific Review Officer, Grants Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4226, MSC 9550, Bethesda, MD 20892–9550, 301– 435–1432, liangm@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIH Pathway to Independence Award (K99/R00) Review. Date: March 11, 2015. VerDate Sep<11>2014 17:10 Jan 12, 2015 Jkt 235001 Time: 11:00 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, 301– 402–6020, hiromi.ono@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Abuse Prevention, Drug Testing Advisory Board. Dates/Time/Type: February 5, 2015, from 11:00 a.m. to 5:00 p.m. E.S.T.: CLOSED, February 6, 2015, from 9:00 a.m. to 2:00 p.m. E.S.T.: CLOSED. Place: Sugarloaf Conference Room, SAMHSA Building, 1 Choke Cherry Road, Rockville, Maryland 20850. Contact: Janine Denis Cook, Ph.D., Designated Federal Official, CSAP Drug Testing Advisory Board, 1 Choke Cherry Road, Room 7–1043, Rockville, Maryland 20857, Telephone: 240–276– 2600, Fax: 240–276–2610, Email: janine.cook@samhsa.hhs.gov. Dated: January 7, 2015. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. Janine Denis Cook, Designated Federal Official, DTAB, Division of Workplace Programs, Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration. [FR Doc. 2015–00282 Filed 1–12–15; 8:45 am] [FR Doc. 2015–00310 Filed 1–12–15; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will meet on February 5, 2015, from 11:00 a.m. to 5:00 p.m., and February 6, 2015, from 9:00 a.m. to 2:00 p.m. E.S.T. The DTAB will convene in closed sessions on these two days. On February 5, 2015, from 11:00 a.m. to 5:00 p.m., and February 6, 2015, from 9:00 a.m. to 2:00 p.m., the Board will meet in closed session to discuss confidential hair testing best practices and data, as well as proposed revisions to the Mandatory Guidelines for Federal Workplace Drug Testing Programs. Therefore, this meeting is closed to the public as determined by the Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4), 5 U.S.C. 552b(c)(9)(B), and 5 U.S.C. App. 2, Section 10(d). Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees Web site, https://www. samhsa.gov/about-us/advisory-councils/ drug-testing-advisory-board-dtab, or by contacting Dr. Cook. Committee Name: Substance Abuse and Mental Health Services Administration’s, Center for Substance PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [1651–0121] Agency Information Collection Activities: Trusted Traveler Programs and U.S. APEC Business Travel Card U.S. Customs and Border Protection, Department of Homeland Security. ACTION: 30-Day notice and request for comments; extension of an existing collection of information. AGENCY: U.S. Customs and Border Protection (CBP) of the Department of Homeland Security will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act: Trusted Traveler Programs and U.S. APEC Business Travel Card. This is a proposed extension of an information collection that was previously approved. CBP is proposing that this information collection be extended with no change to the burden hours or to the information collected. This document is published to obtain comments from the public and affected agencies. DATES: Written comments should be received on or before February 12, 2015 to be assured of consideration. ADDRESSES: Interested persons are invited to submit written comments on this proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and SUMMARY: E:\FR\FM\13JAN1.SGM 13JAN1

Agencies

[Federal Register Volume 80, Number 8 (Tuesday, January 13, 2015)]
[Notices]
[Page 1650]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00310]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will meet on February 5, 2015, from 11:00 a.m. to 5:00 
p.m., and February 6, 2015, from 9:00 a.m. to 2:00 p.m. E.S.T. The DTAB 
will convene in closed sessions on these two days.
    On February 5, 2015, from 11:00 a.m. to 5:00 p.m., and February 6, 
2015, from 9:00 a.m. to 2:00 p.m., the Board will meet in closed 
session to discuss confidential hair testing best practices and data, 
as well as proposed revisions to the Mandatory Guidelines for Federal 
Workplace Drug Testing Programs. Therefore, this meeting is closed to 
the public as determined by the Administrator, SAMHSA, in accordance 
with 5 U.S.C. 552b(c)(4), 5 U.S.C. 552b(c)(9)(B), and 5 U.S.C. App. 2, 
Section 10(d).
    Meeting information and a roster of DTAB members may be obtained by 
accessing the SAMHSA Advisory Committees Web site, https://www.samhsa.gov/about-us/advisory-councils/drug-testing-advisory-board-dtab, or by contacting Dr. Cook.
    Committee Name: Substance Abuse and Mental Health Services 
Administration's, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: February 5, 2015, from 11:00 a.m. to 5:00 p.m. 
E.S.T.: CLOSED, February 6, 2015, from 9:00 a.m. to 2:00 p.m. E.S.T.: 
CLOSED.
    Place: Sugarloaf Conference Room, SAMHSA Building, 1 Choke Cherry 
Road, Rockville, Maryland 20850.
    Contact: Janine Denis Cook, Ph.D., Designated Federal Official, 
CSAP Drug Testing Advisory Board, 1 Choke Cherry Road, Room 7-1043, 
Rockville, Maryland 20857, Telephone: 240-276-2600, Fax: 240-276-2610, 
Email: janine.cook@samhsa.hhs.gov.

Janine Denis Cook,
Designated Federal Official, DTAB, Division of Workplace Programs, 
Center for Substance Abuse Prevention, Substance Abuse and Mental 
Health Services Administration.
[FR Doc. 2015-00310 Filed 1-12-15; 8:45 am]
BILLING CODE 4162-20-P